These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. A spatially resolved single-cell genomic atlas of the adult human breast. Kumar T; Nee K; Wei R; He S; Nguyen QH; Bai S; Blake K; Pein M; Gong Y; Sei E; Hu M; Casasent AK; Thennavan A; Li J; Tran T; Chen K; Nilges B; Kashikar N; Braubach O; Ben Cheikh B; Nikulina N; Chen H; Teshome M; Menegaz B; Javaid H; Nagi C; Montalvan J; Lev T; Mallya S; Tifrea DF; Edwards R; Lin E; Parajuli R; Hanson S; Winocour S; Thompson A; Lim B; Lawson DA; Kessenbrock K; Navin N Nature; 2023 Aug; 620(7972):181-191. PubMed ID: 37380767 [TBL] [Abstract][Full Text] [Related]
47. Combating subclonal evolution of resistant cancer phenotypes. Brady SW; McQuerry JA; Qiao Y; Piccolo SR; Shrestha G; Jenkins DF; Layer RM; Pedersen BS; Miller RH; Esch A; Selitsky SR; Parker JS; Anderson LA; Dalley BK; Factor RE; Reddy CB; Boltax JP; Li DY; Moos PJ; Gray JW; Heiser LM; Buys SS; Cohen AL; Johnson WE; Quinlan AR; Marth G; Werner TL; Bild AH Nat Commun; 2017 Nov; 8(1):1231. PubMed ID: 29093439 [TBL] [Abstract][Full Text] [Related]
48. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis. Yoosuf N; Navarro JF; Salmén F; Ståhl PL; Daub CO Breast Cancer Res; 2020 Jan; 22(1):6. PubMed ID: 31931856 [TBL] [Abstract][Full Text] [Related]
49. Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferation. Canu V; Donzelli S; Sacconi A; Lo Sardo F; Pulito C; Bossel N; Di Benedetto A; Muti P; Botti C; Domany E; Bicciato S; Strano S; Yarden Y; Blandino G Cell Death Differ; 2021 May; 28(5):1493-1511. PubMed ID: 33230261 [TBL] [Abstract][Full Text] [Related]
50. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis. Li Z; Li H; Chen J; Luo H; Zeng J; Yao Y; Duan M Int J Biochem Cell Biol; 2020 Sep; 126():105797. PubMed ID: 32668328 [TBL] [Abstract][Full Text] [Related]
51. SPAG5: An Emerging Oncogene. He J; Green AR; Li Y; Chan SYT; Liu DX Trends Cancer; 2020 Jul; 6(7):543-547. PubMed ID: 32291236 [TBL] [Abstract][Full Text] [Related]
52. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer. Li M; Li A; Zhou S; Lv H; Yang W J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840 [TBL] [Abstract][Full Text] [Related]
53. SPAG5 promotes hepatocellular carcinoma progression by downregulating SCARA5 through modifying β-catenin degradation. Liu H; Hu J; Wei R; Zhou L; Pan H; Zhu H; Huang M; Luo J; Xu W J Exp Clin Cancer Res; 2018 Sep; 37(1):229. PubMed ID: 30249289 [TBL] [Abstract][Full Text] [Related]
54. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma. Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483 [TBL] [Abstract][Full Text] [Related]
55. Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer. Morla-Barcelo PM; Laguna-Macarrilla D; Cordoba O; Matheu G; Oliver J; Roca P; Nadal-Serrano M; Sastre-Serra J Breast Cancer Res; 2024 Jun; 26(1):89. PubMed ID: 38831458 [TBL] [Abstract][Full Text] [Related]
56. Microenvironment-induced CREPT expression by cancer-derived small extracellular vesicles primes field cancerization. Lin Y; Jiang H; Li J; Ren F; Wang Y; Qiu Y; Li J; Li M; Wang Y; Yang L; Song Y; Jia H; Zhai W; Kuang Y; Yu H; Zhu W; Liu S; Morii E; Ensinger C; David C; Zheng H; Ji J; Wang H; Chang Z Theranostics; 2024; 14(2):662-680. PubMed ID: 38169511 [No Abstract] [Full Text] [Related]
57. Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis. Patkulkar PA; Subbalakshmi AR; Jolly MK; Sinharay S ACS Omega; 2023 Feb; 8(7):6126-6138. PubMed ID: 36844580 [TBL] [Abstract][Full Text] [Related]
58. Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors. Kulinczak M; Sromek M; Panek G; Zakrzewska K; Lotocka R; Szafron LM; Chechlinska M; Siwicki JK Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140779 [TBL] [Abstract][Full Text] [Related]
59. Field cancerization in breast cancer. Gadaleta E; Thorn GJ; Ross-Adams H; Jones LJ; Chelala C J Pathol; 2022 Jul; 257(4):561-574. PubMed ID: 35362092 [TBL] [Abstract][Full Text] [Related]
60. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics. Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]